内容

目次

1. Behavioural Sciences & Sociocultural Psychiatry 1.1 Fundamentals of psychology 1.1.a Conditioning 1.1.b Shaping and Chaining 1.1.c Social learning theory 1.1.d perceptual organisation 1.1.e Theories of perception 1.1.f Memory 1.1.g Retrieval 1.1.h Ribots Law 1.1.i Memory disorders 1.1.j Memory neuroscience 1.1.k Brain structures invovled in memory 1.2. Baisc and social psychology 1.2.a Personality 1.2.b Emotion 1.2.c Motivation 1.2.d Attitudes 1.2.e Intelligence 1.2.f Cognitive dissonance 1.2.g Self psychology 1.2.h Attribution 1.2.i Theory of mind 1.2.j Controversial studies 1.2.k Groups and conforming 1.2.l. Consent in minors 1.3 Sociocultural Psychiatry 1.3.a Ethics 1.3.b Global ethical policies 1.3.c Human rights 1.3.d Models of illness 1.3.e Family life 1.3.f Theory of Expressed Emotion 1.3.g Society and mental health 1.3.h History of major publications in psychiatry 1.3.i Important figures in Psychiatry 1.3.j Immigration and Schizophrenia 1.3.k Stigma 1.3.l Grief 2. Human Development 2.1 Piaget's theory of cognitive development 2.2 The zone of proximal development 2.3 Kohlberg's theory of moral development 2.4 Freud's stages of psychosexual development 2.5 Erickson's stages of psychosocial development 2.6 Mahler's 'Separation-Individuation' stages of child development 2.7 Table of relevant developmental stages 2.8 Temperament 2.9 Fear 2.10 Speech/language milestones 2.11 Motor milestones 2.12 Attachment theory 2.13 Studies related to attachment 2.14 Mary Ainsworth 2.15 Developmental concepts 2.16 Parenting styles 2.17 Freudian concepts 2.18 Assessment of intelligence 3. Basic neurosciences 3.1 Neuroanatomy 3.1.a Brain development 3.1.b Cranial fossae 3.1.c Meningeal layers 3.1.d Cortical structures 3.1.e. Hemispheric lateralisation 3.1.f Cranial foramina 3.1.g Subcortical structures 3.1.h Thalamus 3.1.i Cerebellum 3.1.j Brain stem and crania nerves 3.1.k White Matter Pathways 3.1.l. Spinal Cord 3.1.m Cerebrospinal Fluid 3.1.n Blood supply 3.1.o Blood-brain barrier 3.2 Neurophysiology 3.2.a The action potention 3.2.b Hypothalamus, pituitary, adrenal axis 3.2.c Adrenal fatigue 3.2.d Thyroid gland 3.2.e Adrenal cortex 3.2.f Dexamethasone Suppression Tests 3.2.g Tremors 3.2.h Electroencephalograms 3.2.i Sleep architecture 3.2.j. Sleep disorders 3.3 Neurochemistry 3.3.a. Classification of receptors XXXX 3.3.b. Biogenic Amines- serotonin, histamine, catecholamine 3.3.c. Noradrenaline 3.3.d MAO 3.3.e. Acetylcholine 3.4. Molecular Genetics 3.4.a DNA 3.4.b. RNA 3.4.c Replication 3.4.d. Transcription 3.4.e. Types of mutation 3.4.f. Translocation 3.4.g. Terminology 3.4.h. Mendellian inheritance 3.4.i. Autosomal dominant 3.4.j. Automsomal recessive 3.4.k. X linked dominant 3.4.l. X linked recessive 3.4.m. Non mendellian inheritance 3.4.n. Mitochondrial 3.4.o. Trinucleotide repeat 3.4.p. Techniques in molecular genetics 3.4.q. Heritability 3.4.r. Concordance 3.4.s. Hardy Weinberg equilibrium 3.4.t. Genetic studies 3.4.u. Schizophrenia genetics 3.4.v. Affective disorders genetics 3.4.w. Autism genetics 3.4.x. ADHD genetics 3.4.y. Summary of genetic conditions 3.5. Clinical Neuropathology 3.5.a. Alzheimers disease 3.5.b. Lewy Body Dementia 3.5.c. Frontotemporal dementia 3.5.d. CJD 3.5.e. Schizophrenia 3.5.f. Parkinsons Disease 3.5.g. Summary of pathological findings 3.6. Applied neurosciences 3.6.a. Frontal Lobe testing 3.6.b. Parietal lobe 3.6.c. Temporal lobe lesions 3.6.d. Temporal lobe epilepsy 3.6.e. Apraxia 3.6.f. Lanugage- production, wernickse, brocas, conduction, anomic 3.6.g. Agnosia 4. Clinical Psychopharmacology 4.1 Mechanisms of action 4.1.a Dementia drugs 4.1.b Antidepressants 4.1.c. Antipsychotics 4.1.d. Clozapine 4.1.e. Mood stabilisers 4.1.f. Benzodiazepines 4.1.g. Z drugs 4.1.h. Other drugs 4.2. Specifics of prescribing 4.2.a. Prescribing in pregnancy 4.2.b. Prescribing in breast feeding 4.2.c. Effects on sleep 4.2.d. Benzodiazepine 4.2.e. Antipsychotic extrapyramidal side effects 4.2.f. Antipsychotic risk of weight gain 4.2.g. Antipsychotic hyperprolactinaemia 4.2.h. Overview antipsychotic side effects 4.2.i. Clozapine side effects 4.2.j. SSRIs side effect 4.2.k. Tricyclic antidepressant side effects 4.2.l. Tricyclic antidepressant drug interactions 4.2.m. Mono-Amine oxidase inhibitors side effects 4.2.n. Mono-Amine oxidase inhibitors drug interactions 4.2.o. Psychiatric side-effects of non-psychiatric drugs 4.2.p. Factors affecting medication adherence 4.3. Pharmacokinetics 4.3.a. Key aspects 4.3.b. Blood-brain barrier 4.3.c. Bioavailability and bioequivalence 4.3.d. Metabolism of drugs 4.3.e. Excretion 4.3.f. Clearance 4.3.g. Indices of safety and efficacy 4.3.h. Variable affecting pharmacokinetics 5. Classification and Assessment 5.1. Classification 5.1.a. Diagnostic manuals 5.1.b. Changes from DSM-5 to DSM-5 5.1.c. Approaches to classification 5.2. History and Mental State Examination 5.2.a. The psychiatric history 5.2.b. Cogntiive function 5.2.c. The neurological examination 5.2.d. Blood investigations 5.2.e. Specialist dementia scans 5.2.f. Delirium 5.2.g. Eating Disorders 5.2.h. Intelligence Quotient 5.2.i. Assessment scales 5.3. Psychopathology 5.3.a. Thought disorders 5.3.b. Classifying thought form 5.3.c. Explanatory models 5.3.d. Classifying thought form 5.3.e. Disorders of speech 5.3.f. Disorders of memory 5.3.g. Disorders of mood and affect 5.3.h. Disorders of perception 5.4. Diagnosis and ICD-10 Classification Codes 5.4.a. ICD-10 vs. DSM-IV 5.4.b. F00-09 Organic, including symptomatic, mental disorders 5.4.c. F10-F19 Mental and Behavioural Disorders due to psychoactive Substance Use 5.4.d. F20-F29 Schizophrenia, schizotypal and delusional disorder 5.4.e. F30-F39 Mood (affective disorders) 5.4.f. F40-49 Neurotic, stress-related and somatoform disorders 5.4.g. F50-59 Behavioural syndromes associated with physiological disturbances and physical factors 5.4.h. F60-69 Disorders of adult personality and behaviour